![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
A more recent version of this article appeared on June 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 29, 2007
Revised on March 9, 2007
Accepted on March 29, 2007
Laboratory of Molecular Cardiology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1762
Monitoring Editor: Paul Forscher
Ablation of nonmuscle myosin (NM) II-B in mice during embryonic development leads to marked enlargement of the cerebral ventricles and destruction of brain tissue, due to hydrocephalus. We have identified a transient mesh-like structure present at the apical border of cells lining the spinal canal of mice during development. This structure, which only contains the II-B isoform of NM, also contains 
-catenin and N-cadherin, consistent with a role in cell adhesion. Ablation of NM II-B or replacement of NM II-B with decreased amounts of a mutant (R709C), motor-impaired NM II-B in mice results in collapse of the mesh-like structure and loss of cell adhesion. This permits the underlying neuroepithelial cells to invade the spinal canal and obstruct cerebral spinal fluid flow. These defects in the CNS of NM II-B ablated mice appear to be the cause of hydrocephalus. Interestingly, the mesh-like structure and patency of the spinal canal can be restored by increasing expression of the motor-impaired NM II-B, which also rescues hydrocephalus. However, the mutant isoform cannot completely rescue neuronal cell migration. These studies show that the scaffolding properties of NM II-B play an important role in cell adhesion thereby preventing hydrocephalus during mouse brain development.
This article has been cited by other articles:
|
|
 |
|
  R. F. Robledo, S. L. Ciciotte, B. Gwynn, K. E. Sahr, D. M. Gilligan, N. Mohandas, and L. L. Peters Targeted deletion of {alpha}-adducin results in absent {beta}- and {gamma}-adducin, compensated hemolytic anemia, and lethal hydrocephalus in mice Blood, November 15, 2008; 112(10): 4298 - 4307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, A. Tewari, S. Einheber, J. L. Salzer, and C. V. Melendez-Vasquez Myosin II has distinct functions in PNS and CNS myelin sheath formation J. Cell Biol., September 22, 2008; 182(6): 1171 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Wylie and P. D. Chantler Myosin IIC: A Third Molecular Motor Driving Neuronal Dynamics Mol. Biol. Cell, September 1, 2008; 19(9): 3956 - 3968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Conti and R. S. Adelstein Nonmuscle myosin II moves in new directions J. Cell Sci., January 1, 2008; 121(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bao, X. Ma, C. Liu, and R. S. Adelstein Replacement of Nonmuscle Myosin II-B with II-A Rescues Brain but Not Cardiac Defects in Mice J. Biol. Chem., July 27, 2007; 282(30): 22102 - 22111. [Abstract] [Full Text] [PDF]
|
|
